Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Breast Cancer

Free Subscription 06.07.2020 3 AJR Am J Roentgenol 2 Am J Surg 3 Ann Surg Oncol 3 BMC Cancer 4 Breast Cancer 2 Breast Cancer (Auckl) 2 Breast Cancer Res 13 Breast Cancer Res Treat 2 Breast J 3 Cancer 1 Cancer Epidemiol Biomarkers Prev 2 Cancer Lett 1 Cancer Res 1 Clin Breast Cancer 1 Eur Radiol 1 Exp Cell Res 1 Histopathology 2 J Biol Chem 3 J Clin Oncol 1 J Nucl Med 1 J Surg Oncol 1 Lancet 2 Lancet Oncol 1 N Engl J Med 1 Nat Rev Clin Oncol 1 Oncology (Williston Park) 4 PLoS One 1 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. BUTLER RS, Hooley RJ
   Screening Breast Ultrasound: Update After 10 Years of Breast Density Notification Laws.
   AJR Am J Roentgenol. 2020 Mar 17:1-12. doi: 10.2214/AJR.19.22275.
   PubMed         Abstract available
   
   
2. MANGO VL, Sun M, Wynn RT, Ha R, et al
   Should We Ignore, Follow, or Biopsy? Impact of Artificial Intelligence Decision Support on Breast Ultrasound Lesion Assessment.
   AJR Am J Roentgenol. 2020 Apr 22:1-8. doi: 10.2214/AJR.19.21872.
   PubMed         Abstract available
   
   
3. DODELZON K, Simon K, Dou E, Levy AD, et al
   Performance of 2D Synthetic Mammography Versus Digital Mammography in the Detection of Microcalcifications at Screening.
   AJR Am J Roentgenol. 2020 Apr 7:1-9. doi: 10.2214/AJR.19.21598.
   PubMed         Abstract available
   
   

   
   Am J Surg

4. HUANG J, Chagpar A
   Effect of decision-making resources on satisfaction with decision to undergo contralateral prophylactic mastectomy (CPM).
   Am J Surg. 2020;219:1036-1038.
   PubMed         Abstract available
   
   
5. WEN B, Mousadoust D, Warburton R, Pao JS, et al
   Phyllodes tumours of the breast: Outcomes and recurrence after excision.
   Am J Surg. 2020;219:790-794.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

6. WEISS A, King TA, Mittendorf EA
   The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer.
   Ann Surg Oncol. 2020 Jun 26. pii: 10.1245/s10434-020-08530.
   PubMed         Abstract available
   
   
7. SUN J, Mathias BJ, Sun W, Fulp WJ, et al
   Is it Wise to Omit Sentinel Node Biopsy in Elderly Patients with Breast Cancer?
   Ann Surg Oncol. 2020 Jul 1. pii: 10.1245/s10434-020-08759.
   PubMed         Abstract available
   
   
8. BAILEY CM, Selber J, Liu J, Lee CN, et al
   Current Practice and Perceptions Regarding Cost Communication in Breast Cancer Reconstruction: Survey Results of the American Society of Plastic Surgeons.
   Ann Surg Oncol. 2020 Jul 1. pii: 10.1245/s10434-020-08750.
   PubMed         Abstract available
   
   

   
   BMC Cancer

9. TAKADA K, Kashiwagi S, Asano Y, Goto W, et al
   Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer.
   BMC Cancer. 2020;20:598.
   PubMed         Abstract available
   
   
10. MEZEI T, Hajdu M, Czigleczki G, Lotz G, et al
    Sterile, abscess-like cerebral lesion during trastuzumab therapy after HER2 status switch in a triple negative breast cancer patient: a case report and literature review.
    BMC Cancer. 2020;20:615.
    PubMed         Abstract available
    
    
11. WANG J, Cai Y, Yu F, Ping Z, et al
    Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies.
    BMC Cancer. 2020;20:601.
    PubMed         Abstract available
    
    

    
    Breast Cancer

12. CHONG F, Wang Y, Song M, Sun Q, et al
    Sedentary behavior and risk of breast cancer: a dose-response meta-analysis from prospective studies.
    Breast Cancer. 2020 Jun 30. pii: 10.1007/s12282-020-01126.
    PubMed         Abstract available
    
    
13. BANDO H, Kataoka A, Tamaki K, Kobayashi M, et al
    Physician's knowledge, attitudes and practice pattern for breast cancer diagnosed during pregnancy: a survey among breast care specialists in Japan.
    Breast Cancer. 2020 Jun 26. pii: 10.1007/s12282-020-01118.
    PubMed         Abstract available
    
    
14. TANAKA N, Hirano A, Hattori A, Ogura K, et al
    Effect of adjuvant chemotherapy in patients with ER + /HER2- breast cancer, assessed by propensity score matching: significance of nuclear grade and nodal status.
    Breast Cancer. 2020 Jun 26. pii: 10.1007/s12282-020-01125.
    PubMed         Abstract available
    
    
15. TAJIRI W, Ijichi H, Takizawa K, Koi Y, et al
    The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.
    Breast Cancer. 2020 Jun 29. pii: 10.1007/s12282-020-01130.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Auckl)

16. MISHRA A, Bonello M, Byron A, Langdon SP, et al
    Evaluation of Gene Expression Data From Cybrids and Tumours Highlights Elevated NDRG1-Driven Proliferation in Triple-Negative Breast Cancer.
    Breast Cancer (Auckl). 2020;14:1178223420934447.
    PubMed         Abstract available
    
    
17. ALSHARI O, Aleshawi A, Al Sharie AH, Msameh A, et al
    The Effect of Nail Lacquer on Taxane-Induced Nail Changes in Women With Breast Cancer.
    Breast Cancer (Auckl). 2020;14:1178223420929702.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

18. BYERLY JH, Port ER, Irie HY
    PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim.
    Breast Cancer Res. 2020;22:72.
    PubMed         Abstract available
    
    
19. TERKELSEN T, Russo F, Gromov P, Haakensen VD, et al
    Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
    Breast Cancer Res. 2020;22:73.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

20. YAO J, Liu Y, Cheng J
    Standardize the management procedures for breast cancer patients during the outbreak of COVID-19 in Wuhan, China.
    Breast Cancer Res Treat. 2020 Jun 27. pii: 10.1007/s10549-020-05743.
    PubMed         Abstract available
    
    
21. CHEN FM, Huang LJ, Ou-Yang F, Kan JY, et al
    Activation of mitochondrial unfolded protein response is associated with Her2-overexpression breast cancer.
    Breast Cancer Res Treat. 2020 Jun 29. pii: 10.1007/s10549-020-05729.
    PubMed         Abstract available
    
    
22. YANG X, Zhao L, Pei J, Wang Z, et al
    CELF6 modulates triple-negative breast cancer progression by regulating the stability of FBP1 mRNA.
    Breast Cancer Res Treat. 2020 Jun 29. pii: 10.1007/s10549-020-05753.
    PubMed         Abstract available
    
    
23. KHALEFA HG, Shawki MA, Aboelhassan R, El Wakeel LM, et al
    Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study.
    Breast Cancer Res Treat. 2020 Jun 29. pii: 10.1007/s10549-020-05762.
    PubMed         Abstract available
    
    
24. HACKSHAW MD, Danysh HE, Singh J, Ritchey ME, et al
    Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer.
    Breast Cancer Res Treat. 2020 Jun 26. pii: 10.1007/s10549-020-05754.
    PubMed         Abstract available
    
    
25. GUO D, Hendryx M, Liang X, Manson JE, et al
    Association between selenium intake and breast cancer risk: results from the Women's Health Initiative.
    Breast Cancer Res Treat. 2020 Jun 30. pii: 10.1007/s10549-020-05764.
    PubMed         Abstract available
    
    
26. WANG DG, Barrios DM, Blinder VS, Bromberg JF, et al
    Dermatologic adverse events related to the PI3Kalpha inhibitor alpelisib (BYL719) in patients with breast cancer.
    Breast Cancer Res Treat. 2020 Jun 29. pii: 10.1007/s10549-020-05726.
    PubMed         Abstract available
    
    
27. WALTER V, Fischer C, Deutsch TM, Ersing C, et al
    Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer.
    Breast Cancer Res Treat. 2020 Jul 1. pii: 10.1007/s10549-020-05746.
    PubMed         Abstract available
    
    
28. SPECHT M, Sobti N, Rosado N, Tomczyk E, et al
    High-Efficiency Same-Day Approach to Breast Reconstruction During the COVID-19 Crisis.
    Breast Cancer Res Treat. 2020;182:679-688.
    PubMed         Abstract available
    
    
29. CAVAZZA M, Banks H, Ercolanoni M, Cukaj G, et al
    Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management.
    Breast Cancer Res Treat. 2020 Jun 26. pii: 10.1007/s10549-020-05748.
    PubMed         Abstract available
    
    
30. PERACHINO M, Poggio F, Lambertini M
    Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer.
    Breast Cancer Res Treat. 2020 Jun 28. pii: 10.1007/s10549-020-05767.
    PubMed        
    
    
31. ACCORDINO MK, Wright JD, Buono D, Lin A, et al
    Incidence and Predictors of Diabetes Mellitus after a Diagnosis of Early-Stage Breast Cancer in the Elderly Using Real-World Data.
    Breast Cancer Res Treat. 2020 Jun 26. pii: 10.1007/s10549-020-05756.
    PubMed         Abstract available
    
    
32. DONAHUE PMC, Crescenzi R, Lee C, Garza M, et al
    Magnetic resonance imaging and bioimpedance evaluation of lymphatic abnormalities in patients with breast cancer treatment-related lymphedema.
    Breast Cancer Res Treat. 2020 Jun 29. pii: 10.1007/s10549-020-05765.
    PubMed         Abstract available
    
    

    
    Breast J

33. NGASERIN S, Chua HW, Chew MH, Tan BK, et al
    A tripartite approach can seek to optimize breast cancer management during a pandemic - Real-Time experience of a developing breast oncology unit in Singapore.
    Breast J. 2020 Jul 1. doi: 10.1111/tbj.13961.
    PubMed        
    
    
34. CASELLA D, Fusario D, Cassetti D, Miccoli S, et al
    The patient's pathway for breast cancer in the COVID-19 era: An Italian single-center experience.
    Breast J. 2020 Jun 28. doi: 10.1111/tbj.13958.
    PubMed         Abstract available
    
    

    
    Cancer

35. GUO F, Scholl M, Fuchs EL, Berenson AB, et al
    BRCA testing in unaffected young women in the United States, 2006-2017.
    Cancer. 2020;126:337-343.
    PubMed         Abstract available
    
    
36. SONG Y, Barry WT, Seah DS, Tung NM, et al
    Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.
    Cancer. 2020;126:271-280.
    PubMed         Abstract available
    
    
37. SHEPPARD VB, Dash C, Nomura S, Sutton AL, et al
    Physical activity, health-related quality of life, and adjuvant endocrine therapy-related symptoms in women with hormone receptor-positive breast cancer.
    Cancer. 2020 Jul 2. doi: 10.1002/cncr.33054.
    PubMed         Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

38. LANGE M, Hardy-Leger I, Licaj I, Pistilli B, et al
    Cognitive impairment in breast cancer patients before surgery: results from a CANTO cohort subgroup.
    Cancer Epidemiol Biomarkers Prev. 2020 Jul 1. pii: 1055-9965.EPI-20-0346.
    PubMed         Abstract available
    
    

    
    Cancer Lett

39. WU J, Yan J, Fang P, Zhou HB, et al
    Three-dimensional oxabicycloheptene sulfonate targets the homologous recombination and repair programmes through estrogen receptor alpha antagonism.
    Cancer Lett. 2020;469:78-88.
    PubMed         Abstract available
    
    
40. NAN X, Wang J, Cheng H, Yin Z, et al
    Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.
    Cancer Lett. 2020;469:195-206.
    PubMed         Abstract available
    
    

    
    Cancer Res

41. BANIK D, Noonepalle S, Hadley M, Palmer E, et al
    HDAC6 plays a non-canonical role in the regulation of anti-tumor immune responses, dissemination, and invasiveness of breast cancer.
    Cancer Res. 2020 Jun 30. pii: 0008-5472.CAN-19-3738.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

42. CO M, Kwong A
    Breast Cancer Rate and Mortality in Female Flight Attendants: A Systematic Review and Pooled Analysis.
    Clin Breast Cancer. 2020 May 12. pii: S1526-8209(20)30095.
    PubMed         Abstract available
    
    

    
    Eur Radiol

43. MAO N, Yin P, Li Q, Wang Q, et al
    Radiomics nomogram of contrast-enhanced spectral mammography for prediction of axillary lymph node metastasis in breast cancer: a multicenter study.
    Eur Radiol. 2020 Jun 30. pii: 10.1007/s00330-020-07016.
    PubMed         Abstract available
    
    

    
    Exp Cell Res

44. LIU JH, Chen C, Li ZY, Zou ZM, et al
    The MyD88 inhibitor TJ-M2010-2 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88/GSK-3beta and MyD88/NF-kappaB signalling pathways.
    Exp Cell Res. 2020 Jun 28:112157. doi: 10.1016/j.yexcr.2020.112157.
    PubMed         Abstract available
    
    

    
    Histopathology

45. DOWNES MR, Slodkowska E, Katabi N, Jungbluth AA, et al
    Interobserver and Intraobserver agreement of PD-L1 scoring in Head and Neck Squamous Cell Carcinoma (HSCC), Urothelial Carcinoma (UC), and Breast Carcinoma (BC).
    Histopathology. 2019 Jun 27. doi: 10.1111/his.13946.
    PubMed         Abstract available
    
    

    
    J Biol Chem

46. 
    Expression of Concern: Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis.
    J Biol Chem. 2020;295:8876.
    PubMed        
    
    
47. 
    Expression of Concern: Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation.
    J Biol Chem. 2020;295:8886.
    PubMed        
    
    

    
    J Clin Oncol

48. CHLEBOWSKI RT, Aragaki AK, Prentice RL
    Dietary Moderation and Deaths From Breast Cancer.
    J Clin Oncol. 2020 Jul 2:JCO2001218. doi: 10.1200/JCO.20.01218.
    PubMed        
    
    
49. DESMEDT C, Fornili M, Clatot F, Demicheli R, et al
    Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass Index.
    J Clin Oncol. 2020 Jul 2:JCO1901771. doi: 10.1200/JCO.19.01771.
    PubMed         Abstract available
    
    
50. RAYSON D
    Camouflage.
    J Clin Oncol. 2020;38:281-282.
    PubMed        
    
    

    
    J Nucl Med

51. PETERSON LM, Kurland BF, Yan F, Novakova-Jiresova A, et al
    (18)F-Fluoroestradiol ((18)F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.
    J Nucl Med. 2020 Jun 26. pii: jnumed.120.244459. doi: 10.2967/jnumed.120.244459.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

52. BOLAND MR, Ryan EJ, Nugent T, Gilroy D, et al
    Impact of progesterone receptor status on response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer patients.
    J Surg Oncol. 2020 Jul 1. doi: 10.1002/jso.26096.
    PubMed         Abstract available
    
    

    
    Lancet

53. MURRAY BRUNT A, Haviland JS, Wheatley DA, Sydenham MA, et al
    Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
    Lancet. 2020;395:1613-1626.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

54. BENSON JR
    Quality of life after breast-conserving surgery for women with non-low-risk ductal carcinoma in situ.
    Lancet Oncol. 2020;21:612-614.
    PubMed        
    
    
55. MALEKPOUR M, Widger J
    Radiation-induced angiosarcoma in a patient with breast cancer.
    Lancet Oncol. 2020;21:e369.
    PubMed        
    
    

    
    N Engl J Med

56. SPRING LM, Specht MC, Jimenez RB, Isakoff SJ, et al
    Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic.
    N Engl J Med. 2020 Jul 1. doi: 10.1056/NEJMcpc2002422.
    PubMed        
    
    

    
    Nat Rev Clin Oncol

57. PASHAYAN N, Antoniou AC, Ivanus U, Esserman LJ, et al
    Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
    Nat Rev Clin Oncol. 2020 Jun 29. pii: 10.1038/s41571-020-0412.
    PubMed         Abstract available
    
    

    
    Oncology (Williston Park)

58. 
    Assessing the Impact of TAILORx on Breast Cancer Management.
    Oncology (Williston Park). 2020;34:224-226.
    PubMed         Abstract available
    
    

    
    PLoS One

59. TANAKA M, Hsuan C, Oeki M, Shen W, et al
    Identification of characteristic compounds of moderate volatility in breast cancer cell lines.
    PLoS One. 2020;15:e0235442.
    PubMed         Abstract available
    
    
60. THURING J, Kuhl CK, Barabasch A, Hitpass L, et al
    Signal changes in T2-weighted MRI of liver metastases under bevacizumab-A practical imaging biomarker?
    PLoS One. 2020;15:e0230553.
    PubMed         Abstract available
    
    
61. RAINES MILENKOV A, Felini M, Baker E, Acharya R, et al
    Uptake of cancer screenings among a multiethnic refugee population in North Texas, 2014-2018.
    PLoS One. 2020;15:e0230675.
    PubMed         Abstract available
    
    
62. HAILU HE, Mondul AM, Rozek LS, Geleta T, et al
    Descriptive Epidemiology of breast and gynecological cancers among patients attending Saint Paul's Hospital Millennium Medical College, Ethiopia.
    PLoS One. 2020;15:e0230625.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

63. MULLIEZ T, Barbe K, de Ridder M
    Estimating lung cancer and cardiovascular mortality in female breast cancer patients receiving radiotherapy.
    Radiother Oncol. 2020 Mar 26. pii: S0167-8140(20)30153.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: